In this month’s “Hot Topic,” Audrey Schuetz, M.D., highlights the updated laboratory detection guidelines for Clostridioides (Clostridium) difficile and their interpretation in light of clinical disease.
In this month’s “Hot Topic,” Anja Roden, M.D., discusses mesothelial proliferations, their challenges, and which ancillary testing might help to overcome some of those challenges.
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted opioid screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of patients who are prescribed opioid pain-relieving medication.
In this month’s “Hot Topic,” Elitza Theel, Ph.D., discusses the role of serologic testing as it relates to SARS-CoV-2, the virus that causes COVID-19.
In this month’s “Hot Topic,” Matthew Binnicker, Ph.D., will provide an overview of coronaviruses associated with severe respiratory illness, review the two main laboratory tests, and discuss the factors that influence the sensitivity of PCR for detecting SARS-CoV-2 in patients with COVID-19.
In this month’s “Hot Topic,” Rondell Graham, M.B.B.S., provides an overview of a PRKACA FISH test that assists in differentiating fibrolamellar carcinoma from other subtypes of primary liver cancer.
In this month’s “Hot Topic,” Robin Patel, M.D., will discuss the diagnosis of Helicobacter pylori infection in an era of antimicrobial resistance.
In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., will discuss recent information on the advantages and disadvantages of using butterfly needles for blood collection.
In this month’s “Hot Topic,” Sounak Gupta, M.B.B.S., Ph.D., discusses selecting tissues and other tissue considerations for molecular testing. He also reviews tissue metrics and requirements, which differ based on test platforms. It is important to keep in mind that the details of tissue metrics change over time as they continue to evolve with technology.
In this month’s “Hot Topic,” Elitza Theel, Ph.D., talks about Mayo Clinic Laboratories’ serologic and molecular testing for the identification of infection with dengue virus. Dengue virus poses a significant public health threat worldwide. Rapid and accurate identification of the infection enables directed monitoring of patients who may be at increased risk of developing hemorrhagic fever of dengue shock syndrome.
In this month’s “Hot Topic,” Julia Lehman, M.D., will explain important changes that are taking place in Mayo Clinic’s Immunodermatology Laboratory to continue offering the highest quality testing for the interpretation of the bullous pemphigoid 180 and 230 and desmoglein 1 and 3 assay results.
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., will highlight Mayo Clinic’s new targeted benzodiazepine assay and discuss the advantages and limitations of various urine-screening assays as well as quantitative confirmatory testing to determine compliance to benzodiazepine therapy.
